Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aquestive, Astrazeneca, Avenue, Checkpoint, Daiichi Sankyo, Disc, Eli Lilly, Eyepoint, Glyscend, Lipocine, Maat, Merck & Co., Mersana, Newamsterdam, Synthekine Takeda, Telavant, Tonix, Urogen.